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Treatment for upper-limb and lower-limb lymphedema by professionals specializing in lymphedema care
Up to 60% of patients with cancer of the vulva, and between 20 and 30% of patients with breast or abdominal
cancers may develop lymphedema following treatment. The aims of this study were to assess health profes-
sionals’ knowledge about treatment, diagnostic procedures, advice and confidence in treatment of patients
with either upper-limb (ULL) or lower-limb lymphoedema (LLL), and whether these differed by health profes-
sionals’ background or for patients with ULL compared with LLL. A cross-sectional telephone interview was
undertaken in 2006, of 63 health professionals (response rate 92.6%) known to treat lymphedema. Sixty-three
per cent of the health professionals were physiotherapists; the majority were university-trained, with 20 years’
experience or more. Ninety-five per cent of health professionals used circumferential measurements to
establish lymphedema status, and most health professionals advised avoiding scratches and cuts (100%), insect
bites (98.4%), sunburn (98.4%) and excessive exercise (65.1%) on the affected limb. Health professionals
reported that compared with patients with LLL, patients with ULL were more likely to present within the first
3 months of being symptomatic (P < 0.01). Patients with LLL were more likely to present with swelling
(P = 0.001), heaviness (P = 0.003), tightness (P = 0.007) and skin problems (P < 0.001) compared with patients
with ULL. Treatment and advice differed according to health professionals’ background, but not location of
lymphedema (ULL vs. LLL). Assessment, treatment and advice for lymphedema vary across professional
groups. Our results suggest that improvements should be attempted in the early detection of lymphedema, in
particular of LLL among cancer patients.
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INTRODUCTION
Secondary lymphedema after cancer is a condition in
which excess fluid collects in tissue, causing swelling,
most often in the arm(s) (upper-limb lymphedema, or
ULL) and/or leg(s) (lower-limb lymphedema, or LLL), as a
result of removal or damage of lymph nodes and vessels
during surgery or radiotherapy (Wright & Carty 1994;
Board & Harlow 2002).
The exact prevalence of lymphedema among the general
population is unknown (McWayne & Heiney 2005;
Williams et al. 2005), but one study estimated a rate of
1.33/1000 (Moffatt et al. 2003). Estimates of lymphedema
prevalence within cancer populations vary greatly
(Williams et al. 2005). Studies suggest that 5–30% of
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patients treated for breast cancer will develop ULL (Petrek
& Heelan 1998; Hinrichs et al. 2004; Ozaslan & Kuru
2004). Modern treatment for cancers now often employs
lymph node sparing surgery and, therefore, a reduction in
the incidence of lymphedema among breast cancer
patients was expected, but has not been consistently
observed. (Stanton et al. 1996; Benson & della Rovere
2007). It has been suggested that this may reflect improved
case detection, variations in definitions or measurements,
(Hayes et al. 2005) or increased lymphedema prevalence
due to other factors (Bourgeois et al. 1998; Williams et al.
2005).
Compared with ULL, even greater uncertainty exists
regarding the prevalence of LLL after cancer (Logan 1995;
Okeke et al. 2004). Early studies reported LLL in up to
69% of all patients with cancer of the vulva (Podratz &
Symmonds 1983), and between 30% and 49% of patients
may still develop LLL after modern, individualized treat-
ment (De Hullu & Ansink 2001; Gould et al. 2001).
Lower-limb lymphedema has also been reported after
other abdominal cancers, but very limited information
exists regarding prevalence (Okeke et al. 2004). In a cross-
sectional survey with 802 survivors of gynaecological
cancer in Queensland, Australia, 11.3% of all patients
self-reported a diagnosis of LLL, and an additional 13.5%
of patients reported undiagnosed lower-limb swelling
(Beesley et al. 2007), much higher than the 2.4% preva-
lence of lymphedema after treatment for uterine cancer
reported recently from the USA (Abu-Rustum et al. 2006).
While plausible physiological models exist for the role
of manual lymph drainage, hosiery, bandaging and com-
pression garments in alleviating lymphoedema (Mortimer
& Levick 2004), there is little supportive evidence for or
against a particular physical treatment for lymphoedema,
with only three randomized trials suitable for inclusion in
Cochrane review (Badger et al. 2004). To achieve consen-
sus among experts in the absence of scientific direction,
several agencies hosted workshops or ordered reviews and,
in summary, standardization of diagnostic procedures,
advice and treatment provided to patients was recom-
mended (Sitzia et al. 1998). However, it is unknown if
these recommendations have already found implementa-
tion in practice and if they are also applied to LLL.
Given this uncertainty, it was the aim of this study to
assess the characteristics of a selected group of health
professionals known to treat secondary lymphoedema
after cancer in their practices. We wanted to describe how
patients reached their practice, presenting symptoms
noted, diagnostic techniques used and advice and treat-
ment given to patients, and to contrast findings for
patients with LLL with those for patients with ULL. It was
also assessed whether these outcomes differed by health
professional’s background.
MATERIALS AND METHODS
Ethical approval was received by the Queensland Univer-
sity of Technology’s Ethics Committee.
Participants
All 83 health professionals listed within the Lymphedema
Treatment Facilities and Resource Directory compiled by
the Lymphedema Association of Queensland were con-
tacted by letter introducing the project in December 2005.
To be listed in this booklet, health professionals needed to
specify the courses they attended to learn about the treat-
ment of lymphoedema. The letter invited health profes-
sionals to participate in a semi-structured telephone
interview of approximately 20 min. Health professionals
interested to participate were asked to return a consent
form with their preferred time for a call. During the tele-
phone interview, information was collected on character-
istics of health professionals, sources of knowledge about
lymphedema, prevalence of patients with ULL and LLL
within their practices, who referred patients with lymphe-
dema, patients’ status at the time of entering the practice
(diagnosed lymphedema or undiagnosed swelling/other
symptom), and treatment and advice provided to patients
with ULL or LLL. Using open-ended questions, respon-
dents were also invited to comment further on their expe-
rience with the treatment of lymphedema. Telephone
interview data were manually transcribed and then
entered into spss for analysis.
Statistical analysis
Descriptive analysis was performed and crude percentages
were calculated. Differences in diagnosis, treatment and
advice given to patients with ULL and LLL by the health
professionals were explored using non-parametric com-
parisons for related observations (Wilcoxon matched-
pair tests), and differences in treatment and advice for
LLL between health professionals (physiotherapists, oc-
cupational therapists, nurses, massage therapists) were
compared descriptively. Chi-squared analyses were not
conducted for this particular comparison as the assump-
tion of expected cell counts >5 could not be met. The level
of statistical significance was set at P < 0.05.
RESULTS
Of the 83 health professionals contacted, 96.4% (n = 80)
were reached by telephone. Seventeen either declined
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participation (n = 5), were ineligible as they were no longer
practising (n = 2), had taken leave or moved outside the
region (n = 4), or worked jointly with another professional
treating the same group of patients (n = 6).
Of the 63 health professionals interviewed (response
rate among those eligible = 92.6%), the majority were
female, aged 30–49 years (Table 1), with tertiary educa-
tion, and over half (55.6%) had been practising for more
than 20 years. Physiotherapists made up the largest pro-
fessional group (63.5%), followed by occupational thera-
pists (17.5%), nurses (12.5%) and remedial massage
therapists (6.3%). Forty-three per cent of professionals
were hospital-based, whereas 55% worked in solo or group
private practices as their primary occupation. On average,
the health professionals treated three patients for ULL and
two patients for LLL per month, with a wide range in the
number of patients treated. Fifty-seven per cent of health
professionals had treated a patient for ULL, and 50% pro-
vided treatment for LLL, in the last week (Table 2).
The most common sources of knowledge about lymphe-
dema reported were materials produced by patient organi-
zations (69.8%), scientific journals and scientific books
(both 68.3%), postgraduate courses (63%) and the Internet
(50.8%). Approximately one-third of the health profes-
sionals reported sourcing knowledge about lymphedema
via an internship/practicum (36.5%), peers/colleagues
(33.3%) or conferences/workshops (31.7%), and only
25.4% of professionals mentioned undergraduate
education.
Most health professionals (82%) devoted 50% or less of
their time to patients with lymphedema. Only a minority
felt that they received adequate training from their pro-
fessional body to provide lymphedema treatment (30.2%
and 21.7% for ULL and LLL respectively). Significant dif-
ferences by profession were evident with regards to satis-
faction with the adequacy of training from professional
bodies, with occupational therapists least satisfied. Con-
tinuous education was also lacking - 31.7% of health
professionals reported inadequate continuous education
from their professional body regarding treatment for
lymphedema. Nevertheless, more than 90% of profession-
als felt ’very prepared’ to treat lymphedema (Table 2).
Circumferential measurement was the primary method
for diagnosis and monitoring of lymphedema (95.2% and
95.0% for ULL and LLL respectively), although subjective
measures (e.g. skin changes) were also used (55.6% and
50.0%). Other less common diagnostic procedures for ULL
and LLL included bioelectrical impedance (9.5%; 6.7%),
limb-volume measurements via water displacement
(6.3%; 3.3%), referrals for diagnosis to other healthcare
providers (4.8%; 8.3%) and lymphoscintography (4.8%;
8.3%) (Table 2).
There was no difference in advice or prescriptions pro-
vided to patients with ULL or LLL. For example, health
professionals advised all or most of their patients to avoid
scratches and cuts (100%), insect bites (98.4%) and
sunburn (98.4%). Similarly, all or almost all professionals
prescribed self-massage (100%), moderate exercise (96.8%)
and wearing protective clothing while gardening, sewing
or washing up (98.4%). Smaller proportions prescribed
nutritional treatment (20.6%) or herbal treatment (9.5%)
(Table 3).
With regards to referral patterns, health professionals
reported that a greater proportion of patients with ULL
(26.2%) were self-referred compared with LLL (21.7%;
P = 0.05). Health professionals received referral of patients
with lymphedema from a variety of other health profes-
sionals, and they reported that it was more common for
patients with ULL to be referred by a specialist nurse,
surgeon, other physiotherapist or occupational therapist
compared with patients with LLL, who were predomi-
nantly referred by general practitioners. Professionals
reported that 56.1% of patients with ULL had symptoms
for 3 months or fewer before seeing them, whereas only
24.2% of patients with LLL presented within the first
3 months of experiencing symptoms (P < 0.01). The preva-
lence of presenting symptoms also varied by lymphedema
Table 1. Demographic characteristics of participating health pro-
fessionals (n = 63)
Characteristics n %
Sex
Women 61 96.8
Men 2 3.2
Age (years)
<40 20 31.7
40–49 25 39.7
50 18 28.6
Education
University degree 56 88.9
High School plus diploma or
technical certificate
7 11.1
Years of practice
20 28 44.4
>20 35 55.6
Type of professional
Physiotherapist 40 63.5
Occupational therapist 11 17.5
Registered nurse 8 12.7
Remedial massage therapist 4 6.3
Primary mode of practice
Hospital-based 27 42.9
Group practice 17 27.0
Solo practice 12 19.0
Multidisciplinary group practice 6 9.5
Hospice-based 1 1.6
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site, with significantly higher proportions of health pro-
fessionals reporting that patients with LLL always pre-
sented with swelling (P = 0.001), heaviness (P = 0.003),
tightness (P = 0.007) and skin problems (P < 0.001) than
patients with ULL (Table 4).
There was no difference in the treatments provided by
health professionals for patients with ULL or LLL, with
the exception of hydrotherapy, which was less commonly
used for patients with ULL (14.5%) compared with
patients with LLL (23.7%; P = 0.03). Health professionals
most commonly reported treating patients with compres-
sion garments (86.5%), bandaging (72.7%), prescribed
exercises (62.8%) and/or education (60.4%). The majority
of health professionals indicated that treatment was more
effective when the patient presented early (Table 4).
Treatments and advice provided for LLL varied some-
what by profession. Laser and hydrotherapy/aquatic phys-
iotherapy was practised only by physiotherapists and
nurses. Tight-fitting clothes were cautioned by all nurses
and occupational therapists, most physiotherapists
(92.5%), but only 50% of remedial massage therapists.
Moderate exercise was prescribed by all nurses and occu-
pational therapists, and most physiotherapists (97.5%)
and remedial massage therapists (75.0%). However,
excessive exercise was cautioned by 25% of remedial
massage therapists, 65% of physiotherapists, 63.6% of
occupational therapists and 87.5% of nurses. Prescriptive
advice varied regarding the use of skin ointment or mois-
turiser, which were more commonly prescribed by occu-
pational therapists (100%) and nurses (100%) compared
with massage therapists (50%). Herbal treatment was
more commonly prescribed by remedial massage thera-
pists (50.0%) than other professionals (physiotherapists
5.0%, occupational therapists 9.1%, registered nurses
12.5%).
In response to the open-ended questions at the end of
the interview, health professionals reported a range of
presenting symptoms in addition to those queried, in
particular decreased range of movement for patients with
ULL and mobility or gait disturbances for patients with
LLL. Other common advice provided to patients was to
avoid long-distance travel, especially air travel, without
Table 2. Treating characteristics of participating health professionals (n = 63)
n %
Average number of patients treated per month
Patients with ULL: median (min, max) 3 (0, 36)
Patients with LLL: median (min, max) 2 (0, 75)
Recent treatment provided (within last week)
Patients with ULL 36 57.1
Patients with LLL 30 50.0
Proportion of workload devoted to patients with ULL (%)
<50 52 82.5
51–100 11 17.5
Proportion of workload devoted to patients with LLL (%)*
<50 59 98.3
51–100 1 1.7
Adequate training from professional body to treat ULL
Yes 19 30.2
No/don’t know 44 69.8
Adequate training from professional body to treat LLL*
Yes 13 21.7
No/Don’t know 47 78.3
Adequate continuous education from professional body
Yes 20 31.7
No/don’t know 43 68.3
Preparedness to provide treatment for lymphedema
Very prepared 58 92.1
Somewhat prepared 5 7.9
Diagnostic procedures (ULL)
Limb circumference measurement 60 95.2
Subjective measures 35 55.6
Limb volume measurement via water displacement 4 6.3
Bioelectrical impedance 6 9.5
Referral to other health professional for diagnosis 3 4.8
Lymphoscintography 3 4.8
*n = 60 as three professionals treated ULL but not LLL.
ULL, upper-limb lymphedema; LLL, lower-limb lymphedema.
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wearing garments or exercising; to monitor the affected
limb for changes so that early treatment could be sought;
and to swim or exercise in a pool. When the health pro-
fessionals were asked for additional comments regarding
LLL, four main themes arose. Awareness of LLL and its
symptoms, among patients and health professionals, and
understanding of the disease and its treatments remain
poor and contribute to inadequate referral or treatment
delays. Skincare, in particular foot care, was seen as a
significant issue, especially when patients were limited in
their flexibility through limb swelling. Many health pro-
fessionals reported treating LLL more challenging due to a
less cohesive clinical picture and greater resistance to
treatment. Finally, the financial implications of costs for
stockings, compression garments and fees for consulta-
tions are of concern to a large number of patients treated
by the participating health professionals.
DISCUSSION
By contrasting health professionals’ views on the diagnosis
and treatment of ULL and LLL, several notable themes
emerged. First, we observed differences in the treatments
provided by health professionals with different background
training. Variations in treatment for ULL have been noted
previously within the 1998 American Cancer Society
(ACS) Lymphedema Workshop, and this study confirmed
that similar differences exist for treatment of LLL. The
ACS Workshop members concluded that the absence of
standard intervention strategies, common goals for treat-
ment outcomes and an established best practice treatment
may contribute to poor patient compliance with treatment
regimens (Walley et al. 1998; Badger et al. 2004). Further-
more, given the lack of a scientifically established standard
physical treatment (Badger et al. 2004), conflicting treat-
ment information may contribute to distress among
lymphedema patients (Carter 1997). Consumers surveyed
during a review of lymphedema services in Victoria, Aus-
tralia also reported receiving incorrect or conflicting infor-
mation about services, compression garments and funding
subsidies (North Eastern Metropolitan Breast Services
Enhancement Program 2005).
The main sources of knowledge about lymphedema for
the health professionals were postgraduate courses, peers/
colleagues and conferences/workshops. Given that these
educational resources should be equally accessible for all
health professionals regardless of their discipline, greater
consistency in treatments across professions may have
been expected. However, the health professionals sur-
veyed had a large variance in their exposure to patients as
indicated by the wide range in the number of patients
treated per months, and very few of the surveyed profes-
sionals felt that they received adequate training from their
professional body, similar to previous findings (Morgan
et al. 2005). The absence of scientific data to clearly
support a particulate physical treatment as best practice
(Badger et al. 2004) could have further contributed to the
inconsistent treatment across health professional groups
observed within the present study.
Second, our results suggest that treatment for LLL pro-
vides a greater challenge to health professionals than
treatment for ULL due to its lower prevalence, later diag-
nosis, wider variety of presenting symptoms, resistance to
treatment and wider implications for the patients’ health
and social and financial well-being. The lower prevalence
of LLL is reflected in close to 50% of the highly specialized
professionals in our study treating only two patients or
fewer per month. Similarly, vascular surgeons in the UK
reported seeing approximately 10 patients per year with
LLL of any cause (Tiwari et al. 2006). As only 24.2% of
health professionals reported that the majority of patients
with LLL sought treatment within 3 months of symptom
onset (compared with 56.1% reporting such behaviour
among patients with ULL), a greater proportion of patients
with LLL than ULL may have progressed to a chronic stage
of lymphedema before consulting a health professional
with experience in providing treatment. Lower-limb
Table 3. Advice and prescriptions provided by participating
health professionals (n = 63)
n %
Advice to avoid
Scratches and Cuts 63 100.0
Sunburn 62 98.4
Insect bites 62 98.4
Injections on the treated side 61 96.8
Long periods in one position without moving
around
60 95.2
Warm/hot environments 59 93.7
Injury or accident on the treated side 59 93.7
Blood pressure readings on the treated side 59 93.7
Tight-fitting clothes 58 92.1
Gaining weight 55 87.3
Holding or pushing heavy objects with
treated side
49 77.8
Excessive exercise 41 65.1
Prescription
Self-massage 63 100.0
Wear protective clothing while gardening,
sewing or washing up
62 98.4
Moderate exercise 61 96.8
Skin ointment or moisturiser 60 95.2
Raise the limb when sitting 56 88.9
Regularly visit a health professional 47 74.6
Nutritional treatment 13 20.6
Herbal treatment 6 9.5
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lymphedema, compared with ULL, may also have a lower
profile in the public consciousness. Many cancer centres
in Australia, the UK and USA now employ trained breast
cancer nurses who provide patients with specialized ser-
vices and advice, including lymphedema prevention and
early detection. Similar models may also be beneficial for
patients with abdominal cancers and lead to greater
awareness for LLL.
Third, differences in presenting symptoms, diagnosis
and management of lymphedema depending on site
became evident through the answers provided by the
health professionals. Similarly to previous studies (Sitzia
1997), health professionals most commonly used circum-
ferential and subjective measures to diagnose lymphe-
dema of both the upper and lower limbs. As noted before,
greater automation and standardization in measurement
Table 4. Diagnosis and management of lymphedema by site
ULL LLL Wilcoxon
signed
ranks test P-valuen % n %
Referral patterns
Self-referred (mean) 26.2 21.7 -1.92 0.05
Referred by health professionals (mean) 73.8 78.3 -1.92 0.05
Practitioners receive referrals from
General practitioners 58 93.5 49 84.5 -1.89 0.06
Surgeon 46 74.2 31 53.4 -3.36 0.01*
Physiotherapists 45 72.6 32 55.2 -2.89 0.01*
Physician 30 48.4 25 43.1 -1.21 0.23
Specialist nurse 28 45.2 13 22.4 -3.13 0.01*
Occupational therapists 24 38.7 17 29.3 -2.11 0.04*
Palliative care specialist 19 30.6 21 36.2 -0.63 0.53
General nurse 16 25.8 14 24.1 -0.58 0.56
Massage therapists 7 11.3 5 8.6 0.01 0.99
Presenting symptoms†
Swelling 47 74.6 58 96.7 -3.46 0.01*
Heaviness 17 27.0 29 48.3 -2.99 0.01*
Tightness 16 25.4 28 46.7 -2.68 0.01*
Numbness 6 9.5 3 5.0 -0.44 0.66
Pain 4 6.3 7 11.7 -1.50 0.13
Tingling 2 3.2 1 1.7 0.01 0.99
Skin problems 1 1.6 16 26.7 -5.28 0.01*
Treatments provided in last 12 months
Garment provision/referral 53 85.5 52 88.1 0.01 0.99
Bandages 45 72.6 43 72.9 -0.28 0.78
Exercises 39 62.9 37 62.7 0.01 0.99
Education 36 58.1 37 62.7 -0.48 0.66
Massage 21 50.0 31 52.5 -0.38 0.71
Manual lymph drainage 19 30.6 15 25.4 0.33 0.74
Self-massage 17 27.4 13 22 -1.63 0.10
Skin care 17 27.4 20 33.9 -1.13 0.26
Lymphedema self-management‡ 15 24.2 16 27.1 -0.33 0.74
Physical therapy 14 22.6 13 22.0 0.01 0.99
Laser 10 16.1 7 11.9 -1.34 0.18
Complex decongestive therapy§ 9 14.3 6 10.2 -1.34 0.18
Hydrotherapy 9 14.5 14 23.7 -2.24 0.03*
Breathing exercises 5 8.1 6 10.2 -1.34 0.18
Adequate training from professional body to provide treatment for lymphedema
Yes 19 30.2 13 21.7 -1.51 0.13
No/don’t know 44 69.8 47 78.3
Effectiveness of treatment independent of length of symptoms
Yes, equally effective 5 7.9 5 8.3 -0.88 0.38
No, better if patient comes early 58 92.1 53 88.3
ULL, upper-limb lymphedema; LLL, lower-limb lymphedema.
†Number and percentage of health professionals reporting that patients with ULL or LLL always present with this symptom.
‡Lymphedema self-management includes techniques for self-care, such as education, advice/prescriptions, self-massage.
§Complex decongestive therapy includes: manual lymph drainage, bandaging, garment measurement/supply, education, lymphedema
self-management, skin care advice and exercise prescription.
*P < 0.05.
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techniques and use of bioelectrical impedance devices
could improve diagnosis (Sitzia et al. 1998; Cornish et al.
2001). Also integrating limb measurements into the stan-
dard assessment at admission for cancer surgery could be
beneficial, providing personal presurgical measurements
for later contrast. Proper fitting compression garments and
response to massage treatment were harder to achieve for
LLL compared with ULL. In the present study, 30% of
professionals used manual lymph drainage (Foldi 1998) for
patients with ULL and 25% for patients with LLL in the
past 12 months. While this rate of manual lymphatic
drainage as treatment seems comparatively low, others
have found only 5% of lymphedema patients ever receiv-
ing manual lymphatic drainage (Moffatt et al. 2003). This
is important, because, at least anecdotally, use of manual
lymph drainage is considered to improve patient out-
comes (Szuba et al. 2002).
Fourth, we observed relatively high agreement overall
among professionals regarding advice to moderately
exercise but to avoid excessive exercise, although levels
of agreement varied within professional groups. These
results may suggest that most health professionals are
aware of emerging research supporting exercise for
lymphedema (Turner et al. 2004). Also more recent work
highlights that the origin of much advice surrounding
lymphedema, such as avoiding ’overuse’ of the affected
limb, is unknown, and it seems unreasonable to expect
patients to modify their behaviour when no evidence for
such a prescription exists (Rockson 1998; Hayes et al.
2005). Further research is now required to determine the
value of exercise for ULL and LLL.
In summary, this study aimed to compare diagnostic
procedures, treatments and recommendations for patients
with LLL and ULL provided by health professionals
known to treat lymphedema in their practices, likely
reflecting the best of care patients can presently expect.
Further research is needed to improve referral patterns,
especially for patients with LLL, and to collect further
data on treatment outcomes preferably within clinical
trials so that health professionals can provide clear,
evidence-based, consistent diagnosis, advice and treat-
ment to minimize patient distress and improve patient
care.
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